INNOVALVE BIO MEDICAL

Innovalve is a leading medical device company developing catheter-delivered heart valve therapies... The introduction of novel catheter technologies to replace a defective mitral valve may dramatically alter the existing approach for treating mitral regurgitation. Innovalve's TMVR System will allow physicians to offer therapy to patients who suffer from mitral regurgitation, and who currently have no good and safe solution/intervention for their condition. Innovalve's TMVR System has the ability to transform these patients markets from either surgery-based or repair-only options, to include minimally invasive TMVR. Thus, providing clinical benefit comparable to mitral valve replacement surgery, with the lower risks associated with a minimally invasive approach... Founded in 2017 at the Sheba Medical Center, the largest hospital in Israel and recognized among the top 10 in the world by Newsweek in 2019, 2020, 2021, and a teaching hospital of Tel Aviv University. Innovalve's presence..

Also known as: Innovalve, Innovalve Bio Medical Ltd.